Xiaoketongbi Formula vs pregabalin for painful diabetic neuropathy: A single‐center, randomized, single‐blind, double‐dummy, and parallel controlled clinical trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Xiaoketongbi Formula vs pregabalin for painful diabetic neuropathy: A single‐center, randomized, single‐blind, double‐dummy, and parallel controlled clinical trial

Published:2022-08 Issue:8 Volume:14 Page:551-561
ISSN:1753-0393
Container-title:Journal of Diabetes
language:en
Short-container-title:Journal of Diabetes

Author:

Lu Qiyun¹²,Chen Benjian¹²,Liang Qingshun¹²,Wu Liyan¹²,Luo Lulu¹²,Li Anxiang¹²,Ouyang Wenwei¹²,Wen Zehuai¹²,Liu Yunwei³,Lu Jiayan³,Liu Yunyi⁴,Fan Guanjie¹²,Liu Zhenjie¹²^ORCID

Affiliation:

1. Guangdong Provincial Hospital of Chinese Medicine Guangzhou China

2. The Second Affiliated Hospital of Guangzhou University of Chinese Medicine Guangzhou China

3. Guangzhou University of Traditional Chinese Medicine Guangzhou China

4. Guangzhou Medical University Guangzhou China

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1753-0407.13306

Reference41 articles.

1. Estimating the burden of illness of painful diabetic peripheral neuropathy in China;Wang B;Value Health,2014

2. New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain

3. Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes

4. Effect of Prior Intensive Insulin Treatment During the Diabetes Control and Complications Trial (DCCT) on Peripheral Neuropathy in Type 1 Diabetes During the Epidemiology of Diabetes Interventions and Complications (EDIC) Study

5. Pharmacotherapy for diabetic peripheral neuropathy pain and quality of life

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances of traditional Chinese medicine preclinical mechanisms and clinical studies on diabetic peripheral neuropathy;Pharmaceutical Biology;2024-06-30

2. The reporting quality of randomized controlled trials in Chinese herbal medicine (CHM) formulas for diabetes based on the consort statement and its extension for CHM formulas;Frontiers in Pharmacology;2024-01-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3